Li, Gui-zhou
Hu, Ya-hui
Lu, Yi-ni
Yang, Qing-yan
Fu, Di
Chen, Feng
Li, Yun-man
Funding for this research was provided by:
the National Natural Science Foundation of China (81803642, 82073845)
the China Postdoctoral Science Foundation (2019M651903)
the National Major Scientific and Technological Special Project for “Significant New Drugs Development” during the Thirteenth Five-year Plan Period (2018ZX09301043-001)
Jiangsu Research Hospital Association for Precision Medication (JY202010)
Article History
Received: 15 January 2021
Accepted: 24 June 2021
First Online: 20 July 2021
Declarations
:
: The animal study was reviewed and approved by Institutional Animal Care and Use Committee of China Pharmaceutical University (Nanjing, China; licence number: SYXK (Su) 2016-0011).
: Not applicable.
: Not applicable.
: The authors declare no competing interests.